Stifel Financial
YTEN

Stifel Financial’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Stifel Financial’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1
Closed -$27K – 2440
2015
Q1 		$27K Hold
1
– – ﹤0.01% 2255
2014
Q4 		$17K Hold
1
– – ﹤0.01% 2275
2014
Q3 		$41K Hold
1
– – ﹤0.01% 2159
2014
Q2 		$40K Buy
+1
New +$56.3K ﹤0.01% 2148

Other funds holding YTEN

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FA
FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return

Stifel Financial's YTEN Position: Q2 2015 in Review

Stifel Financial sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2015, closing a stake of 1 share — an estimated $27K sold.

Stifel Financial first reported a position in YTEN in Q2 2014 and held it in 4 quarters. The position peaked at $41K in Q3 2014. 11 funds tracked by Wall St. Rank hold YTEN as of Q2 2015.

  • Stifel Financial reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • Stifel Financial sold 1 Yield10 Bioscience, Inc. Common Stock share in Q2 2015, an estimated $27K.
  • Stifel Financial first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2014 and held it in 4 quarters.
  • Stifel Financial's Yield10 Bioscience, Inc. Common Stock position peaked at $41K in Q3 2014.
  • 11 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2015.

Based on Stifel Financial's 13F filing for Q2 2015, filed 17 Aug 2015.